
Gliomas are tumour growths of cells that arise in the spinal cord or brain. Glioma cells are similar to glial cells, which are healthy brain cells. Glial cells support and encompass nerve cells in their function.
A glioma becomes a tumour, which is a collection of cells. The tumour growth can compress the brain or spinal cord, causing symptoms. The location of the affected part of the brain or spinal cord determines the symptoms.
There are many kinds of gliomas. Some are not considered to be malignancies and develop slowly, while others are considered to be malignancies. Malignant is another term that means cancerous. Malignant gliomas can invade normal brain tissue and grow very quickly. Some gliomas are more prevalent in adulthood, while others only occur in children.
The type of glial cells from which gliomas develop determines their classification. The main glioma types are as follows:
Astrocytoma: This originates from astrocytes, which are star-shaped glial cells. They consist of low-grade tumours, which are less malignant, and high-grade tumours, which are more malignant.
Oligodendrogliomas: Oligodendrocytes, the cells that originate oligodendrogliomas, form the myelin sheath that envelops nerve fibres. These tumours tend to develop more slowly.
Ependymomas: The ependymal cells lining the ventricles of the brain and spinal cord lead to ependymomas. Adults and children can develop them.
Glioblastoma (GBM) is among the most vicious and lethal of brain tumours and is a highly malignant and aggressive type of astrocytoma.
Glioma should be treated as early as possible to enhance outcomes and quality of life. Early management can achieve minimal symptoms, reduced tumour growth, and potentially enhanced effectiveness of chemotherapy, radiotherapy, and surgery. Delaying treatment may make the disease more challenging to manage by increasing pressure in the brain, exacerbating neurological deficits, and enhancing tumour growth. Early treatment may improve the options for personalised treatment, which may strengthen long-term survival.
The location of a glioma determines its symptoms. The glioma's size, type, and growth rate may also affect the symptoms.
Causes
Studies have shown that gliomas and other spinal cord and brain cancers result from DNA alterations. DNA is found in our genes, which dictate how cells divide and grow. If the DNA of our genes mutates, cells can grow uncontrollably.
Your parents can pass down genetic mutations. They can also co-occur while you're alive.
Risk Factors
Recent and future studies in India focus on enhancing the treatment of gliomas with advanced tools and therapies. Radiation, chemotherapy, and surgery are the current options, but newer approaches such as immunotherapy, targeted drugs, and gene therapies are also gaining attention. Personalised medicine focuses on treatments based on tumour genetic profiling and is increasingly being researched in India. New drug delivery technologies and proton therapy are some of the latest technologies that can potentially enhance glioma patients' treatment outcomes.
Brain Cancer Treatment: Depending on the type, size, and location of the tumour, glioma is usually treated with a combination of chemotherapy, radiation therapy, and surgery.
Cost Start From USD 7500 - USD 12000Explore Options
Surgery: The first step in treating gliomas is typically to remove the tumour. If the glioma is eliminated, surgery may be the only necessary treatment.
Chemotherapy: Chemotherapy medications are used to kill tumour cells. Chemotherapy drugs are usually given intravenously or orally. Chemotherapy may sometimes be given directly to the glioma cells.
Cost Start From USD 600 - USD 700Explore Options
Radiation Therapy: Radiation destroys tumour cells with high-energy beams. The energy source can be protons, X-rays, or something else. After surgery, radiation therapy is often employed to treat gliomas. The radiation kills the leftover glioma cells after surgery. Radiation and chemotherapy are usually combined.
Targeted Therapy: Targeted therapy treatments focus on specific substances in cancer cells. Targeted therapy treatments can kill cancer cells by inhibiting these substances.
Cost Start From USD 8000 - USD 12000Explore Options
MediRehab (chain of Rehab centres - Part of MediGence) provides comprehensive rehabilitation services designed to support Glioma patients in India. These services include:









Delhi, India

Gurgaon, India

Mumbai, India
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
India's advanced medical technology, well-trained medical professionals, and low-cost care make it an attractive destination for glioma treatment. Compared to most Western countries, patients are provided top-notch care at a fraction of the price due to access to cutting-edge treatments such as proton therapy, targeted therapies, and trained neurosurgeons. In world-class hospitals with shorter waiting times, Glioma patients would benefit from India's holistic care, including surgery, radiation, and rehabilitation.
The following are the main differences between high-grade and low-grade gliomas:
Surgery is usually advised in India for glioma, but it is not always necessary in all cases. Surgery is decided based on various factors, such as the tumour's type, size, and location and the patient's general health.
Gliomas may recur after treatment. Recurrence depends on several factors, such as the location, grade, and type of the glioma. Due to their aggressive nature, glioblastoma and other high-grade gliomas are more likely to recur. Despite successful initial treatment, glioma cells might remain in the brain, which may result in the tumour's recurrence.
Survival in glioma depends on the location, grade, and type of tumour. The prognosis for low-grade gliomas is generally favourable, with 5-year survival ranging from 60% to 80%. Glioblastoma and high-grade gliomas, however, have an inferior prognosis with a median survival of 12 to 18 months and a 5-year survival of around 5% to 10%. While outcomes can be optimised with early detection and treatment, survival remains unpredictable.
The following lifestyle modifications can help in the management of glioma symptoms: